Journals / European Journal of Therapeutics / 2018 / Cilt: 24 - Sayı: 1
Point Reached in Targeted Therapy; Where are we?
- Pages
- 19–25
- DOI
- —
Abstract
Lung cancer is a very important public health problem. Identification of new molecular targets and development of novel therapies related to activated immune cytotoxic cells are significant steps in achieving the goal of personalized therapy in lung cancer.